Study identifier:D961HC00006
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
A multicentre, randomised, double-blind, parallel-group, comparative study to compare the efficacy and safety of esomeprazole 20 mg once daily oral administration with omeprazole 10 mg and esomeprazole 10 mg once daily oral administration in maintenance treatment in patients with healed reflux esophagitis
reflux esophagitis
Phase 3
No
Esomeprazole, Omeprazole
All
540
Interventional
20 Years +
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment
Verified 01 May 2010 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
No locations available
Arms | Assigned Interventions |
---|---|
Experimental: 1 Esomeprazole and Omeprazole | Drug: Esomeprazole 10mg once daily oral administration Other Name: Nexium Drug: Omeprazole 10mg once daily oral administration Other Name: Prilosec |
Experimental: 2 Esomeprazole | Drug: Esomeprazole 20mg once daily oral administration Other Name: Nexium |